Previous Article | Next Article 
Journal of Bacteriology, December 1998, p. 6607-6616, Vol. 180, No. 24
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
A MADS Box Protein Consensus Binding Site Is
Necessary and Sufficient for Activation of the Opaque-Phase-Specific
Gene OP4 of Candida albicans
Shawn R.
Lockhart,
Mau
Nguyen,
Thyagarajan
Srikantha, and
David R.
Soll*
Department of Biological Sciences, University
of Iowa, Iowa City, Iowa 52242
Received 20 August 1998/Accepted 7 October 1998
 |
ABSTRACT |
The majority of strains of Candida albicans can switch
frequently and reversibly between two or more general phenotypes, a process now considered a putative virulence factor in this species. Candida albicans WO-1 switches frequently and reversibly
between a white and an opaque phase, and this phenotypic transition is accompanied by the differential expression of white-phase-specific and
opaque-phase-specific genes. In the opaque phase, cells differentially express the gene OP4, which encodes a putative protein 402 amino acids in length that contains a highly hydrophobic amino-terminal sequence and a carboxy-terminal sequence with a pI of 10.73. A series
of deletion constructs fused to the Renilla reniformis luciferase was used to functionally characterize the OP4
promoter in order to investigate how this gene is differentially
expressed in the white-opaque transition. An extremely strong 17-bp
transcription activation sequence was identified between
422 and
404 bp. This sequence contained a MADS box consensus binding site,
most closely related to the Mcm1 binding site of Saccharomyces
cerevisiae. A number of point mutations generated in the MADS box
consensus binding site as well as a complete deletion of the consensus
site further demonstrated that it was essential for the activation of
OP4 transcription in the opaque phase. Gel mobility shift
assays with the 17-bp activation sequence identified three specific
complexes which formed with both white- and opaque-phase cell extracts. Competition with a putative MADS box consensus binding site from the
promoter of the coordinately regulated opaque-phase-specific gene
PEP1 (SAP1) and the human MADS box consensus binding site for serum response factor demonstrated that one of the three complexes formed was specific to the OP4 sequence.
 |
INTRODUCTION |
Candida albicans and a
number of related species undergo high-frequency phenotypic switching
between a number of general phenotypes distinguishable, in most cases,
by differences in colony morphology and, in some cases, by differences
in cellular morphology (36, 42, 43, 45, 48, 49). Switching
represents a developmental program distinct from the bud-hypha
transition, although some of the same characteristics, including the
expression of particular phase-specific genes, are regulated by both
programs (4, 45, 55). Since switching has been demonstrated
to affect a number of different putative virulence factors (4, 21,
22, 30, 44, 45, 57), including expression of the drug-resistant gene CDR3 (6), it has been suggested that it
represents, in its own right, a virulence factor that provides the cell
with the ability to respond rapidly to changes in its environment
(46). Different strains of C. albicans may
express different repertoires of colony morphologies, but the general
characteristics of the switching process in all strains tested are
surprisingly similar (45), and some of the same genes are
regulated by switching in different strains (32, 45, 49). To
understand how switching is regulated, a reverse-genetics approach has
been undertaken in which the regulatory circuitry which controls the
expression of phase-specific genes is being tracked upstream with the
expectation that it will lead to the switch event itself (48,
49). In this pursuit, the white-opaque transition in C. albicans WO-1 (43) has been used as a model system
since it involves a simple and reversible transition between a white-
and an opaque-colony-forming phenotype that is accompanied by dramatic
alterations in cellular morphology and physiology (3, 5, 38, 44,
45). It has been demonstrated that the white-opaque transition is
accompanied by the differential expression of phase-specific genes
(30, 31, 44, 48, 49, 51). Transcriptional regulation of the white-phase-specific gene WH11 (51) has been
demonstrated to be effected through two strong and one weak
transcription activation sequence in the promoter, and gel retardation
experiments suggest that white-phase-specific transcription activation
factors interact with the two strong activation sequences (52,
55).
Here, we have functionally characterized for the first time the
promoter of an opaque-phase-specific gene, OP4
(31). OP4 is differentially expressed in the
opaque phase of the white-opaque transition in strain WO-1; it is
silent in both the budding and the hyphal phenotypes of the white phase
(31). OP4 is also differentially expressed in the
variant phenotypes, but not in the basic smooth white phenotype, of the
switching repertoire of the common laboratory strain 3153A
(32). OP4 encodes a putative protein
(31) containing 402 amino acids that has no significant
homology with any protein described to date in available computer
databases. OP4 contains a hydrophobic amino terminus of 26 amino acids, a pI of 10.73 for the last 100 amino acids, two serine
repeats adjacent to alanine repeats, and possible
-helical
conformation within the alanine-rich sequences. The OP4
promoter functions ectopically in a phase-specific manner
(54) and has been used to misexpress the
white-phase-specific gene WH11 in the opaque phase
(26). To understand how OP4 is regulated in the
white-opaque transition, the promoter has been functionally
characterized by fusing deletion and point mutation constructs of the
promoter to the luciferase gene RLUC of the sea pansy
Renilla reniformis, an effective reporter in C. albicans (54), and analyzing transformants for Rluc
activity in the white and opaque phases. Phase-specific factors which
may interact with regulatory sequences have been investigated by gel
retardation experiments. It is demonstrated that OP4
expression is regulated primarily by a strong transcription activation
sequence which consists almost exclusively of a MADS box consensus
binding site with strong homology to the Mcm1 binding site of
Saccharomyces cerevisiae (1, 2).
 |
MATERIALS AND METHODS |
Maintenance of stock cultures.
Red 3/6, an ade2
auxotrophic derivative (56) of C. albicans WO-1
(43), was stored at
80°C. For experimental purposes, cells from stock cultures were plated on agar containing supplemented Lee's medium (7) with 0.6 µM adenine sulfate
(52). Transformants which acquired adenine prototrophy were
maintained in the absence of adenine sulfate. White- and opaque-phase
cells were obtained by growing cells from a white- or an opaque-phase
colony, respectively, in supplemented Lee's liquid medium without
adenine sulfate at 25°C. The proportions of white-phase and
opaque-phase cells were determined microscopically for each cell
population (3, 5, 43), and only populations which contained
>97% of the expected cell type were used for biochemical analysis.
Construction of promoter derivatives.
Deletion and mutation
derivatives of the OP4 promoter were inserted at the
multiple cloning site immediately upstream of the open reading frame of
the R. reniformis luciferase gene (RLUC) in the
transforming plasmid pCRW3, which contains the C. albicans ADE2 gene (54). Construction of the plasmid pCROP31,
which contained the 854-bp region upstream of OP4, has been
described in detail in a previous study (54). Deletion and
mutation derivatives were derived by using the oligonucleotide primers
described in Fig. 1 to generate PCR
products with a
clone containing a 10-kb genomic fragment of
OP4 (31) as template (Table
1). All deletion derivatives were
sequenced. The PCR products were inserted into plasmid pCRW3 either as
a PstI fragment (CROP82, CROP83, CROP84, and CROP85) or as a
PstI/SmaI fragment (CROP12, CROP9, CROP86, CROP7,
M1, M3, M5, M6, M7, M8, M9, M10, and M11). CROP23 was generated by
cleaving pCROP31 with SacI and religating the plasmid to
create a 115-bp deletion. pO
MADS was created by cleaving CROP85 with SmaI and SalI in the polylinker and then
directionally inserting PCR fragment CROP32. pOWhyb was created by
directionally inserting PCR fragment WHM4A at the AflII site
of plasmid pCRW5
Af (55), which contains the transcription
start site of the white-phase-specific gene WH11 upstream of
RLUC. To generate point mutations, oligonucleotides carrying
one or more specific point mutations of the OP4 promoter were used in PCRs with
OP4 as template. All point mutations were confirmed by sequencing.
For integrative transformation of
C. albicans, 20 µg of
each plasmid was linearized within the
ADE2 gene with
NsiI. The details
of integration at the
ade2
locus of strain Red 3/6 have been described
in detail in earlier
publications (
52-54). Transformations were
performed by the
lithium acetate method as described by Schiestl
and Geitz
(
40). Each transformant was analyzed by Southern blot
analysis, and only those that contained a single insertion at
the
ade2 locus were used in subsequent
analyses.
Southern blot analysis.
Total cellular DNA was extracted
from C. albicans isolates according to the method of Scherer
and Stevens (39). Approximately 5 µg of DNA from
transformant clones was digested with either BamHI or
EcoRI, electrophoresed in a 0.8% agarose gel, transferred to a Nitropure membrane (MSI, Westborough, Mass.) and probed with 32P-labeled ADE2. Blots were washed
(12) and exposed to X-OMAT X-ray film (Kodak, Inc.,
Rochester, N.Y.) at
70°C.
Northern blot analysis.
Methods for the isolation of total
cell RNA and Northern blot hybridization have been described in earlier
publications (30, 51). Blots were first probed with
32P-labeled OP4 and autoradiographed, then
stripped, hybridized with 32P-labeled C. albicans
ADE2, a constitutively expressed gene, and autoradiographed again.
In vitro luciferase assays.
C. albicans cells were
grown to late log phase in supplemented Lee's liquid medium
(7). Cells (2 × 108) were washed once with
sterile distilled water and once with luciferase buffer (0.5 M NaCl,
0.1 M K2HPO4 [pH 6.7], 1 mM EDTA, 0.6 mM
sodium azide, 1 mM phenylmethylsulfonyl fluoride, 0.02% bovine serum
albumin) (29). The cell pellet was mixed with an equal
volume of glass beads (0.45-µm diameter) and 200 µl of luciferase buffer and lysed with a bead beater (Biospec Products, Bartlesville, Okla.) through five cycles of 30-s duration, with intervening 1-min
periods of no agitation in an ice bath. One hundred microliters of
luciferase buffer containing 0.5 µM coelenterazine (Molecular Probes
Inc., Eugene, Oreg.) was mixed with either 2 µl of undiluted cell
extract, 2 µl of cell extract diluted 1:10 with luciferase buffer, or
2 µl of cell extract diluted 1:100 with luciferase buffer, in a 4-ml
analysis tube (Analytical Luminescence Laboratory, Ann Arbor, Mich.).
The coelenterazine was stored in acid-methanol at
20°C. Immediately
after cell extract and reaction buffer were mixed, light emission was
measured at 480 nm in the integration mode for 30 s in a Monolight
2010 luminometer (Analytical Luminescence Laboratory). Relative light
units (RLUs) are presented as light emitted per 30 s per microgram
of protein. Protein concentrations were measured by the Bradford assay
(Bio-Rad Laboratories, Hercules, Calif.).
Gel mobility shift assays.
Cells were grown in supplemented
Lee's liquid medium (7) to late log phase and then lysed
according to methods previously described (52). Cell
extracts contained between 10 and 12 mg of protein per ml. The
incubation medium contained the following constituents: 25 mM HEPES (pH
7.9), 50 mM NaCl, 1 mM EDTA, 0.05% Nonidet P-40, 1 mM dithiothreitol,
5% glycerol, 5 µg of poly(dG-dC), and 7.5 µg of cellular extract,
with or without 5 mM MgCl2. Approximately 12 µl of this
mixture was incubated for 10 min at 25°C with or without unlabeled
competitor DNA, as noted in Results. Fifty picograms of
32P-end-labeled DNA was then added, and the mixture was
incubated for an additional 30 min at 25°C. Four microliters of a
solution containing 25 mM HEPES, 50 mM NaCl, 1 mM EDTA, 0.01% xylene
cyanol, and 0.01% bromophenol blue was added to each tube, and the
tubes were then placed on ice prior to loading. Mixtures were loaded on
a 3, 4, or 7% nondenaturing gel (39:1 acrylamide-to-bisacrylamide ratio in buffer containing 22.3 mM Tris-HCl [pH 8.1], 22.3 mM boric
acid, 1 mM EDTA) which had been prerun for 1 h at 110 V. Gel
electrophoresis was performed at a constant 100 V at 4°C for 6 h. Gels were transferred to Whatman 3MM paper, dried, and autoradiographed.
Oligonucleotide pairs M4 and M4A, M1 and M1A, and M5 and M5A (Table
1)
were annealed by being boiled for 10 min in Sequenase
buffer (U.S.
Biochemicals, Cleveland, Ohio), followed by slow
cooling to room
temperature. Double-stranded oligonucleotides
were purified on a 10%
polyacrylamide gel (39:1) followed by elution
in a solution containing
10 mM Tris HCl (pH 7.5) and 1 mM
EDTA.
 |
RESULTS |
The white-opaque transition and OP4 expression.
Red 3/6, the ade2 auxotrophic derivative of strain WO-1 used
in this study, underwent the white-opaque transition (Fig.
2A) at spontaneous frequencies comparable
to those of parental strain WO-1 (3, 43, 44). OP4
was previously demonstrated to be transcribed exclusively in the opaque
phase of the parental strain WO-1 (31), and that was also
true for the ade2 derivative Red 3/6 (Fig. 2B).

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 2.
The white-opaque transition of the adenine auxotroph Red
3/6 of C. albicans WO-1 and differential expression of
OP4 in the opaque phase. (A) Cells of strain Red 3/6 switch
spontaneously and reversibly at 25°C at frequencies of approximately
10 3 between a white- and an opaque-colony-forming
phenotype. This reversible transition is accompanied by a distinct
change in cellular morphology. White-phase cells are round while
opaque-phase cells are twice as large, on average, and elongated and
contain a large vacuole. (B) Opaque-phase cells of strain Red 3/6
differentially express the gene OP4. Northern blots of
white- and opaque-phase cells were probed with OP4 and the
constitutively expressed gene ADE2. Even though Red 3/6 is
an adenine auxotroph, the mutant ade2 gene is constitutively
expressed. Bar, 2 µm.
|
|
The upstream region of OP4.
The 854-bp region upstream
of the OP4 open reading frame contained several consensus
sequences of elements which play cis-acting roles in the
regulation of transcription in other systems (Fig. 3). Between
533 and
520 bp, there was
a C-rich region (C box) (Fig. 3) that is also present in the upstream
region of the opaque-phase-specific secreted aspartyl proteinase gene
PEP1 (47), also referred to as SAP1
(57). Two TATA box consensus sequences (10) were
present at
329 bp and at
187 bp (Fig. 3). A MADS box consensus
binding sequence (33) was present between bp
416 and
403
and represented a perfect palindrome (Fig. 3). The sequence of this
MADS box consensus binding site showed greater homology to the Mcm1
binding site of S. cerevisiae (1) than to other
MADS box consensus sequences, including the Rlm1 binding site of
S. cerevisiae (13), the serum response factor
(SRF) binding site of humans (35), the Mef2a binding site of
humans (33), and the more degenerate AGAMOUS binding site of
plants (17) (Fig. 4). Two PRE
consensus sequences (23) were present at
559 and
454 bp
(Fig. 3). In S. cerevisiae, PRE sequences are binding sites
for Ste12 (14, 16). Ste12 and Mcm1 have been shown to
interact in the regulation of transcription in S. cerevisiae
(19, 34, 41).

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 3.
The 854-bp sequence immediately upstream of the
translational start site of opaque-phase-specific gene OP4.
PRE, consensus sequences of binding sites for Ste12 of S. cerevisiae (14, 16, 23); C-box, a C-rich sequence also
identified in the upstream region of the coordinately activated,
opaque-phase-specific gene PEP1 (SAP1) (30); MADS
box binding site, MADS box consensus binding site homologous with the
Mcm1 binding site of S. cerevisiae (2); TATA,
TATA box consensus sequence (10); tsp, transcription start
point.
|
|

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 4.
Homology between the MADS box consensus binding site in
the OP4 promoter and MADS box consensus binding site of
S. cerevisiae, humans, and plants. Shown are Mcm1 binding
site of S. cerevisiae (1), Rlm1 binding site of
S. cerevisiae (13), AGAMOUS binding site of
Arabidopsis (17), SRF binding site of humans
(35), and Mef2a binding site of humans (33). Grey
boxes denote conserved nucleotides.
|
|
Functional characterization of deletion derivatives of the
OP4 promoter.
The promoter of OP4,
therefore, contains several putative cis-acting sequences
that have been shown to play cis-acting regulatory roles in
S. cerevisiae as well as in higher eukaryotes. However, if
any of these or other promoter sequences in fact play regulatory roles
in the phase-specific transcription of OP4, it was essential first to functionally characterize the promoter through the analysis of
deletion derivatives (52, 55). The plasmid pCROP31 contains the 854-nucleotide untranslated upstream region of OP4 fused
to the RLUC open reading frame (Fig.
5A) and was previously demonstrated to
regulate luciferase expression in an accurate phase-specific manner
during the white-opaque transition when integrated at the ectopic
ade2 locus in Red 3/6 (54). pCROP31 and the
deletion derivatives pCROP23, pCROP12, pCROP9, pCROP8.2, pCROP8.3,
pCROP8.4, pCROP8.6, pCROP8.5, pCROP7, and pCRW3 (Fig. 5B) were each
linearized at the ADE2 locus and then used to transform the
ade2 derivative strain Red 3/6. In each case, 10 independent
transformants were chosen for Southern analysis to verify site-specific
integration at the ade2 locus of strain Red 3/6. All
transformants contained bands at 20.0 and 11.0 kb, which represented
expected fragments containing the endogenous ade2 gene of
Red 3/6. In addition, all transformants contained a 4.6-kb band which
represented the plasmid-derived E fragment of the plasmid
(54). pCROP31, pCROP8.2, pCROP8.3, pCROP8.4, and pCROP8.5
transformants contained a 1.2-kb band, which did not contain
OP4 promoter sequences because of the presence of an extra
BamHI site not deleted during cloning of the promoter (data
not shown). The pCROP23 transformant contained a fragment that was 2.7 kb. This fragment became progressively smaller in the subsequent
deletion constructs pCROP12, pCROP10, and pCROP9 since it contained the
sequentially smaller OP4 promoter sequence (Fig. 5B). In the
case of these latter constructs, the plasmids were cloned as
PstI/SmaI fragments and the BamHI site
was not deleted during cloning. The 11- and 20-kb bands containing the endogenous ade2 locus of Red 3/6 were approximately equal in
intensity in all individual transformants and in untransformed Red 3/6. However, the plasmid bands of transformant clones of a particular construct differed in intensity, indicating differences in the number
of plasmid inserts. Since BamHI sites flanking the
integration site were involved in the genesis of fragments with
variable intensity in the Southern blots, and since there were no
variations in the size of fragments between independent clones of the
same construct, differences in the intensity of fragments encompassing
the plasmid must represent differences in the number of tandem repeats
at the ade2 locus of Red 3/6. This conclusion was supported
by the observation that Rluc activity correlated with the varying
intensity of inserts in transformants in which RLUC was
activated (data not shown). We, therefore, selected 1 to 4 of the 10 transformants of each construct with bands at 4.6 and either 2.7 or 1.2 kb that had intensities reflecting a single copy of the plasmid insert. Unfortunately, none of the 10 transformants of pCROP10 had band intensities consistent with a single insert, so a pCROP10 transformant was not included in the functional analysis of the OP4
promoter.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 5.
Functional characterization of the OP4
promoter through a set of deletion derivatives. (A) Model of the
OP4 promoter. Sequences homologous to known regulatory
sequences in the promoters of other genes as well as the C box also
found in the promoter of the coordinately regulated PEP1
(SAP1) gene are noted. The sequence of the promoter is
presented in Fig. 3. ORF, open reading frame. (B) Activity of Rluc
under the regulation of the deletion derivatives of the OP4
promoter in the opaque and white phases of switching. s.d., standard
deviation; Op., opaque; Wh., white; Diff., difference.
|
|
In Fig.
5A, a model of the
OP4 promoter is presented in
which landmark sequences are identified. In Fig.
5B, Rluc activities
in
the white and opaque phases are presented for the series of
deletion
constructs. Rluc activity in the opaque phase of the
transformant
harboring CROP31, which contained the entire 854-bp
upstream region of
OP4, was considered maximum expression. Deletion
of the
first 115 bp of the promoter region, between

854 and

739
bp in
CROP23, resulted in a reduction of approximately 40% of
Rluc activity
in the opaque phase (Fig.
5B). Deletion of the next
51 bp, between

739 and

688 bp in CROP12, and subsequent deletions
of the next 194 bp, between

688 and

494 bp in CROP9, and between

494 and

461 bp
in CROP8.2, which removed the first Ste12 binding
site consensus
sequence and C box, resulted in no additional decrease
in Rluc activity
in the opaque phase (Fig.
5B). Sequential deletions
of the next 22 and
18 bp in CROP8.3 and CROP8.4, respectively,
which removed the second
Ste12 binding site consensus sequence,
resulted in a further reduction
of 45% of Rluc activity in the
opaque phase (Fig.
5B). Although the
cumulative deletions between

854 and

422 bp reduced activity by
approximately 80%, the remaining
20% was still approximately 1,600 times the level measured in
the promoterless construct CRW3 (Fig.
5B).
Deletion of the next
3 bp to nucleotide

419 in CROP8.6 resulted in a
further decrease
of approximately 20% in activity, but this level of
activity was
still 275 times that of the promoterless construct CRW3
(Fig.
5B). Deletion of the next 15 bp, between

419 and

404 bp in
CROP8.5,
however, resulted in the nearly complete loss of Rluc activity
in the opaque phase, an activity change from 4.4 × 10
5 ± 9.7 × 10
4 to 7.9 × 10
2 ± 3.5 × 10
2 RLUs (Fig.
5B). This
deletion removed all but the most proximal
base pairs of the MADS box
consensus binding site (Fig.
3). Subsequent
deletion of the next 24 bp,
between

404 and

380 bp in CROP7,
which removed the rest of the MADS
box consensus binding site,
had no additional effect on the level of
Rluc activity in the
opaque phase, and complete deletion of the
OP4 promoter (CRW3)
resulted in Rluc activity similar to
that of CROP8.5 and CROP7.
These results suggest that a region
beginning between

419 and

404 bp contains a transcription
activation sequence. This region
coincides with the palindromic MADS
box consensus binding site.
These results also suggest that regions
upstream of

419 bp play
a role in activation and that the region
between

404 bp and the
transcription start site has no intact
activation
sequence(s).
OP4 expression in the white phase of the white-opaque
transition is undetectable by Northern analysis in either strain WO-1
(
31) or the
ade2 derivative Red 3/6 (Fig.
2B).
The activity
of Rluc in the white phase of the transformant harboring
CROP31,
which contains the entire 854-bp promoter region of
OP4 upstream
of
RLUC, was 1/29 that in the opaque
phase. Because each population
of white-phase cells can contain up to a
few percent opaque cells
resulting from spontaneous switching (
33,
43-45), it is not clear
what portion of white-phase activity is
due to a basal level of
white-phase expression and what portion is due
to the unpredictable
levels of opaque-phase cell contamination.
Deletions between

854
and

422 bp resulted in a general decline in
activity in the white
phase to roughly 30% of the activity of the
full-length promoter
construct (Fig.
5B). However, a deletion between

422 and

419
bp in CROP8.6 decreased activity to 6% that of the
full promoter,
and a deletion between

419 and

404 bp in CROP8.5,
the region
containing the upstream portion of the MADS box consensus
binding
site, resulted in the complete loss of the Rluc activity (Fig.
5B). Subsequent deletions, including full-length promoter deletion
(CRW3), had no additional effect on Rluc activity (Fig.
5B). The
complete loss of Rluc activity after deletion of the MADS box
consensus
binding site was, therefore, similar in both white-
and opaque-phase
cells.
Mutations in the C. albicans MADS box consensus binding
site diminish OP4 transcription.
In order to
demonstrate that an intact MADS box consensus binding site is necessary
for OP4 transcription, a number of point mutations of the
consensus binding site were generated in CROP8.6, which is a deletion
derivative beginning at nucleotide
419, 3 bp upstream from the MADS
box consensus sequence. CROP8.6 supported transcription at a level
133-fold higher than that of the promoterless construct CRW3 (4.4 × 105 ± 9.7 × 104 versus 1.6 × 103 ± 1.0 × 103 RLUs) but 9-fold lower
than that of CROP8.4 (4.4 × 105 versus 3.9 × 106 RLUs) (Fig. 5B). A series of palindromic point
mutations were generated that were based on those changes in the Mcm1
binding site of S. cerevisiae that resulted in loss of
function (1). These mutations included one with nucleotide
transitions (CRM11) as well as several with nucleotide transversions
(CRM7, CRM8, CRM9, and CRM10) (Table 2).
The majority of point mutations resulted in activities between 0.8 and
2% that of CROP8.6, which contained the unmodified MADS box consensus
binding site (Table 2). All of these
mutant constructs retained palindromic sequences. In two of the
generated mutants, mammalian MADS box sequences were substituted for
the C. albicans MADS box consensus sequence. In mutant CRM1,
the SRF consensus binding site sequence was substituted, and in CRM3,
the MEF2A consensus binding site sequence was substituted (33). Both contained intact palindromes, but only CRM3
exhibited significant activity (Table 2).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Functional characterization of the OP4 MADS
box consensus sequence through a set of mutations including
transitions and transversionsa
|
|
In the last two mutant constructs, MADS box-like sequences identified
in the promoters of two additional phase-regulated genes,
the
opaque-phase-specific gene
PEP1 (SAP1) (
31,
47)
and the
white-phase-specific gene
WH11 (
51,
52,
55), were substituted
for the
OP4 MADS box consensus
binding site. In construct CRM5,
nucleotides

418 to

405 of
OP4 were substituted with nucleotides

557 to

544 of
PEP1 (
SAP1) (
47), and in construct
CRM6, nucleotides

417 to

405 of
OP4 were substituted
with nucleotides

128 to

115 of
WH11 (
52,
55).
Neither of these mutations activated
transcription in the opaque phase,
leading to the conclusion that
activation of
OP4
transcription is regulated by
cis-acting sequences
different
from those regulating the other opaque-phase-specific
gene
PEP1 and the white-phase-specific gene
WH11.
The Mcm1 consensus binding region is necessary for transcription of
the OP4 gene.
Nested 5' deletions suggested that there
were sequences upstream of the OP4 MADS box consensus
binding site that enhanced the level of MADS box-activated
OP4 transcription, but these deletions did not represent
direct tests for the presence of redundant sites in the upstream region
that functioned in the absence of the MADS box. To test for redundant
sites, a construct was made in which the nucleotide sequence between
416 and
405 of the 854 nucleotides of the OP4 promoter,
which contained two-thirds of the downstream portion of the MADS box,
was replaced with polylinker in the construct O
MADS (Fig. 6A and
B). O
MADS did not support
transcription. The level of Rluc activity in the transformant harboring
O
MADS upstream of RLUC was only slightly higher
(eightfold) than that in the transformant harboring the promoterless
construct CRW3 (Fig. 6C). This result demonstrates that no
transcription activation sequences reside upstream of the MADS box
consensus binding site that can activate gene transcription in a
phase-specific manner.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 6.
Functional characterization of the OP4 MADS
box consensus sequence through substitution of consensus sequence with
polylinker (O MADS) and replacement of the promoter downstream of the
consensus sequence with the downstream region of the WH11
promoter (OWhyb). (A) Models of the two constructs O MADS and OWhyb.
(B) Sequence of the substitution in O MADS. The OP4
activation sequence is highlighted. (C) Activity of Rluc under the
regulation constructs O MADS and OWhyb. Note that CROP31 contain the
complete OP4 promoter and that CRW3 is a promoterless
construct. Op., opaque; Wh., white; s.d., standard deviation; Diff.,
difference.
|
|
In a final construct, the
OP4 activation sequence was placed
upstream of the transcriptional start region of the
WH11
promoter,
which in turn was placed upstream of
RLUC in
construct OWhyb (Fig.
6A). Transformants containing the parental
plasmid pCRW5

Af were
previously shown to have no luciferase activity
in either the
white or the opaque phase (
55). In OWhyb, the
nucleotide sequence
of
OP4 between

854 and

399, which
contains the MADS box consensus
binding site, was fused to the
nucleotide sequence of
WH11 between

85 and

1 (
52,
55), which contains the transcription start
site and TATA binding
region of the WH11 promoter, but not the
two transcription activation
domains. This construct tested whether
any sequence proximal to the
MADS box consensus binding sequence
was necessary for activation at the
latter site. The level of
Rluc activity in the transformant harboring
OWhyb in the opaque
phase was similar to that of pCROP31, which harbors
the entire
OP4 promoter (Fig.
6C). In the white phase of
this transformant,
there was no Rluc activity (Fig.
6C), demonstrating
that the
OP4 activation sequence is sufficient for
opaque-phase-specific activation.
These data confirm that the
C. albicans MADS box consensus binding
site is both necessary and
sufficient to promote opaque-phase
transcription, even with chimeric
downstream promoter
sequences.
Complex formation between the OP4 promoter and cell
protein extract components.
Gel mobility shift assays were
performed with an oligonucleotide containing the 14-bp MADS box
consensus binding site sequence of the OP4 promoter flanked
by the 16 upstream and 8 downstream nucleotides. When opaque-phase cell
extract was used in the assay, the four complexes CI, CII, CIII, and
CIV formed (lane 3, Fig. 7A). No
complexes formed in a negative control in which no protein extract was
added (lane 1, Fig. 7A), and no complexes formed in a negative control
in which bovine serum albumin was added in place of protein extract
(lane 2, Fig. 7A). When the same oligonucleotide in an unlabeled form
was used at 100× concentration as a competitor of binding, formation
of three of the radiolabeled complexes, CII, CIII, and CIV, was reduced
(lane 4, Fig. 7A), and when the oligonucleotide was used as a
competitor at 1,000× and 5,000×, formation of these latter three
radiolabeled complexes was undetectable (lanes 5 and 6, Fig. 7A). These
results demonstrate that complexes CII, CIII, and CIV formed as a
result of interactions between the oligonucleotide containing the MADS
box consensus binding site and components of opaque-phase cell extract.
When similar gel shift assays were performed with white- rather than
opaque-phase cell extract, virtually identical results were obtained
(Fig. 7B), demonstrating that no detectable phase-specific complexes formed with the 38-bp oligonucleotide containing the OP4
transcription activation sequence.

View larger version (65K):
[in this window]
[in a new window]
|
FIG. 7.
Gel mobility shift assays with an oligonucleotide
containing the MADS box consensus binding site flanked by 16 upstream
and 8 downstream nucleotides of the OP4 promoter and either
white- (A) or opaque-phase (B) cell extract. Lanes 1, no protein
extract; lanes 2, bovine serum albumin in place of protein extract;
lanes 3, white- or opaque-phase protein extract; lanes 4, 5, and 6, increasing concentrations of unlabeled oligonucleotide containing the
putative MADS box consensus binding site of OP4; lanes 7, 8, and 9, increasing concentrations of unlabeled oligonucleotides
containing the putative MADS box consensus binding site of PEP1
(SAP1); lanes 10, 11, and 12, increasing concentrations of
unlabeled oligonucleotide containing the SRF consensus binding site.
Double-stranded oligonucleotides used in the gel mobility shift
experiments include OP4 (M4 and M4A in Fig. 1), the 38 bp of
the OP4 promoter containing the MADS box consensus binding
site; PEP1 (SAP1) (M5 and M5A in Fig. 1), the 38 bp of the
OP4 promoter in which the OP4 MADS box consensus
binding site is replaced with the putative MADS box consensus binding
site in the promoter of the gene PEP1 (SAP1)
(30), which is coordinately regulated with OP4
(31); and SRF (M1 and M1A), the 38 bp of the OP4
promoter in which the OP4 MADS box consensus binding site is
replaced with the SRF binding site of humans (35). Lower
exposures discriminated the two bands CIV and CIII in the lanes
containing no competitor, OP4 competitor, and 100× SRF
competitor (data not shown).
|
|
PEP1 (SAP1) is coordinately regulated with
OP4 in
the white-opaque-phase transition (
31). To test whether the
putative MADS
box consensus binding site in the
OP4 promoter
region plays a
role in the formation of complexes CII, CIII, and CIV, a
sequence
in the
PEP1 (SAP1) promoter region with homology to
the
OP4 MADS
box consensus binding site was substituted for
the homologous
portion in the oligonucleotide used as a competitor in
the gel
mobility assay. The
PEP1 (SAP1)-derived
oligonucleotide competed
for complex CII but not for complexes CIII or
CIV (lanes 7, 8,
and 9, Fig.
7), suggesting that formation of the CII
complex is
not affected by the nucleotide differences between the
OP4 and
PEP1 (SAP1) MADS box consensus binding
sites, while formation
of the CIII and CIV complexes
is.
In a similar fashion, the binding site for SRF (
35), which
is homologous to the greater portion of the
OP4 MADS box
consensus
binding site, was replaced in the oligonucleotide used as a
competitor
in the gel mobility shift assay. The SRF-derived
oligonucleotide
competed for complexes CII and CIII but not CIV (lanes
10, 11,
and 12, Fig.
7), suggesting that formation of the CII and CIII
complexes is not affected by the nucleotide differences between
the
OP4 and SRF MADS box consensus binding sites, while
formation
of the CIV complex
is.
 |
DISCUSSION |
Switching in C. albicans and related species occurs
both in commensal and in infecting populations and affects a majority of putative virulence characteristics (4, 6, 18, 21, 22, 45, 46,
57). In the case of C. albicans WO-1, switching between the white and the opaque phases is accompanied by the differential expression of phase-specific genes (48, 49). In
the white phase, cells express the white-phase-specific gene WH11 (51), and in the opaque phase, cells express
opaque-phase-specific genes, including OP4 (31),
PEP1 (SAP1) (30), SAP3
(57), and CDR3 (6). Although the
molecular basis of the fundamental switch event in C. albicans has not been established (48, 49), it seems
likely that the coordinated activation and deactivation of so many
genes in the switching process involve the phase-specific regulation of
trans-acting factors, especially since the phase-specific genes initially analyzed have been demonstrated to be unlinked (31, 51).
The first detailed characterization of a promoter of a C. albicans gene was that of the white-phase-specific gene
WH11 (52). Through the functional analysis of
deletion derivatives of the WH11 promoter, it was
demonstrated that there were two strong and one relatively weak
transcription activation sequence and that the two strong activation
sequences functioned synergistically (52, 55). The results
of this analysis suggested no repressor sequences and led to the
conclusion that WH11 was regulated solely through
activation. Gel mobility experiments using the WH11 promoter and white- or opaque-phase cell extracts identified two
white-phase-specific complexes for each of the strong activation
sequences but no opaque-phase-specific complexes, leading to the
tentative conclusion that white-phase-specific transcription factors
interact with the strong transcription activation sequences to initiate
WH11 transcription in a phase-specific manner (52,
55). Although the upstream region of WH11 contained a number of sequences homologous to the regulatory sequences of genes in
other organisms, none of them fell within the transcription activation
sequences determined by deletion analysis, leading to the conclusion
that the transcription activation sequences for WH11 were
unique (52).
Here, we have undertaken a similar functional characterization of the
promoter of the opaque-phase-specific gene OP4. OP4 is of
particular interest for several reasons. First, it is differentially expressed not only in the opaque phase of strain WO-1 (31)
but also in the variant phenotypes of the switching repertoire of the
laboratory strain 3153A (32). Second, misexpression of
OP4 in the white phase may affect virulence (27).
Here, we have found that one major activation sequence is essential for
OP4 transcription in the opaque phase and that sequences
upstream of this major transcription activation sequence enhance
activation at this site. The major activation sequence is located
within nucleotides
422 and
404. Deletion of the OP4
promoter between nucleotides
854 and
404 or partial replacements of
the activation sequence with polylinker between nucleotides
416 and
405 result in the complete loss of activation. These results
demonstrate that the sequences flanking the activation site both
upstream and downstream are insufficient for activation in the opaque phase.
Perhaps the most intriguing result of this study lies in the sequence
of the 18-bp activation domain of the OP4 promoter. This
region includes a palindromic 14-bp MADS box consensus binding site. Of
the MADS box consensus binding sites so far identified, the sequence
most closely related to that of C. albicans is the binding
site of Mcm1 in S. cerevisiae (Fig. 4). In S. cerevisiae, Mcm1 binds to MADS box binding sites as a dimer
(9, 11, 41). Mcm1 is a global regulator, interacting
combinatorially with other proteins to either activate or repress the
transcription of a number of genes (24). Mcm1 interacts with
MAT
1 to activate genes (15, 50), with MAT
2 to repress
genes (15, 50), and with Ste12 to activate genes (15,
34, 50) in the mating process and cell cycle of S. cerevisiae. It also interacts with Dff to activate genes in the
cell cycle (28). The correlation between the major
transcription activation site of the OP4 promoter and the
conserved MADS box consensus binding sequence of S. cerevisiae (1) suggests that some aspects of phenotypic
switching involve regulation by an Mcm1-like factor in C. albicans, a possibility now being actively pursued.
In a functional analysis of the Mcm1 binding site of an
Mcm1/
2-activated promoter of S. cerevisiae, Acton et al.
(1) demonstrated by point mutation that specific nucleotides
in the site were necessary for activation. We engineered similar point
mutations in the MADS box consensus sequence of the OP4
promoter, and as in the study by Acton et al. (1), all of
the mutations were engineered so that the characteristic palindrome was
maintained. Mutations were generated at five specific nucleotide
positions within the consensus site. All five mutations led to loss of
function. These results were similar to those obtained by Acton et al.
(1) for the Mcm1 binding site with one notable exception.
When an A-to-C transition was made at the second nucleotide of the Mcm1
site, there was only a twofold reduction in activation. In contrast,
the same transition mutation in the OP4 MADS box consensus
site resulted in the complete elimination of activation. Acton et al.
(1) also found that this latter mutation resulted in a
10-fold reduction in repression. While we cannot measure repression in
the white phase at the MADS box consensus binding site of the
OP4 promoter, we have found no increase in activation that
would indicate a reduction in repression in any of the mutations that
we generated in the consensus sequence.
When the MADS box consensus binding site sequence was replaced with the
human MADS box sequence SRF (35) or MEF2A (33), there was no activation in the former case and low, but significant, activation in the latter case. Since OP4 is coordinately
regulated with the opaque-phase-specific gene PEP1
(SAP1) (31) and the white-phase-specific gene
WH11 (51), we also replaced the OP4 MADS box consensus sequence with homologous sequences in the
PEP1 (SAP1) and WH11 promoters. In
neither case did we obtain activation.
To test whether phase-specific protein-DNA interactions occur at the
18-bp activation site of the OP4 promoter in a fashion similar to that demonstrated for the two activation sequences DAS and
PAS of the promoter of the white-phase-specific gene WH11 (52), gel mobility shift assays were performed with white-
or opaque-phase cell extracts. Three specific DNA-protein complexes, CII through CIV, which were verified by competition experiments formed.
Two of the binding complexes, CII and CIII, could each be competed by
one or both of two oligonucleotides with altered MADS box consensus
binding sites. Complex CIV, however, could not be competed with
constructs containing altered MADS box consensus binding sites,
suggesting that there was a stringent requirement for the exact
OP4 MADS box consensus binding site sequence in the
interaction generating CIV complexes. Unlike the WH11
activation domains, none of the three complexes were opaque phase
specific under the conditions employed, and altered magnesium levels
did not affect formation of any of the complexes (27a). If
the complexes represent interactions between the MADS box consensus
binding site and an Mcm1-type protein, this result would not be
surprising since regulation, in this case, might be through
combinatorial protein-protein interactions (56) or
phosphorylation of the Mcm1 protein (25), neither of which
can be as readily assayed by the gel mobility shift assays used in this study.
Recently, Braun and Johnson (8) demonstrated that disruption
of TUP1 results in exclusive growth of C. albicans in the pseudohyphal rather than the yeast form. This has
led to a model in which Tup1 functions as a repressor of genes
necessary for pseudohyphal growth, which when knocked out results in
constitutive pseudohyphal growth. In S. cerevisiae, Tup1 and
Ssn6 are necessary for MAT
2 and Mcm1 to function in the repression
of transcription (20). A similar combinatorial interaction
may be involved in the repression of OP4 transcription in
the white phase of C. albicans WO-1. Indeed, there are
several parallels between the opaque phase and hypha formation
(45), including the inactivation of WH11 transcription (51). The possible roles of Mcm1 and Tup1 in
the regulation of OP4 at the MADS box consensus binding site
are now under intensive investigation.
 |
ACKNOWLEDGMENTS |
We are grateful to Deborah Wessels for help in photographing
living cells.
This work was supported by Public Health Service grants AI39735 and
DE10758 from the National Institutes of Health. S.R.L. was supported by
training grant AG00214 from the National Institutes of Health.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biological Sciences, University of Iowa, Iowa City, IA 52242. Phone: (319) 335-1117. Fax: (319) 335-2772. E-mail:
david-soll{at}uiowa.edu.
 |
REFERENCES |
| 1.
|
Acton, T.,
H. Zhong, and A. Vershon.
1997.
DNA-binding specificity of Mcm1: operator mutations that alter DNA-bending and transcriptional activities by a MADS box protein.
Mol. Cell. Biol.
17:1881-1889[Abstract].
|
| 2.
|
Ammerer, G.
1990.
Identification, purification, and cloning of a polypeptide (PRTF/GRM) that binds to mating-specific promoter elements in yeast.
Genes Dev.
4:299-312[Abstract/Free Full Text].
|
| 3.
|
Anderson, J., and D. Soll.
1987.
Unique phenotype of opaque cells in the white-opaque transition of Candida albicans.
J. Bacteriol.
169:5579-5588[Abstract/Free Full Text].
|
| 4.
|
Anderson, J.,
L. Cundiff,
B. Schnars,
M. Gao,
I. Mackenzie, and D. Soll.
1989.
Hypha formation in the white-opaque transition of Candida albicans.
Infect. Immun.
57:458-467[Abstract/Free Full Text].
|
| 5.
|
Anderson, J.,
R. Mihalik, and D. Soll.
1990.
Ultrastructure and antigenicity of the unique cell wall pimple of the Candida opaque phenotype.
J. Bacteriol.
172:224-235[Abstract/Free Full Text].
|
| 6.
|
Balan, I.,
A. Alareo, and M. Raymond.
1997.
The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter.
J. Bacteriol.
179:7210-7218[Abstract/Free Full Text].
|
| 7.
|
Bedell, G., and D. Soll.
1979.
Effects of low concentrations of zinc on the growth and dimorphism of Candida albicans: evidence for zinc-resistant and -sensitive pathways for mycelium formation.
Infect. Immun.
26:348-354[Abstract/Free Full Text].
|
| 8.
|
Braun, B., and A. Johnson.
1997.
Control of filament formation in Candida albicans by the transcriptional repressor TUP1.
Science
277:105-109[Abstract/Free Full Text].
|
| 9.
|
Bruhn, L.,
S. Hwang, and G. Sprague.
1992.
The N-terminal 96 residues of MCM1, a regulator of cell type-specific genes in Saccharomyces cerevisiae, are sufficient for DNA binding, transcription activation, and interaction with 1.
Mol. Cell. Biol.
12:3563-3572[Abstract/Free Full Text].
|
| 10.
|
Cavallini, B.,
J. Huet,
J. Plassat,
A. Sentenac,
J. Egly, and P. Chambon.
1988.
A yeast activity can substitute for the HeLa cell TATA box factor.
Nature
334:77-80[Medline].
|
| 11.
|
Christ, C., and B. Tye.
1991.
Functional domains of the yeast transcription/replication factor MCM1.
Genes Dev.
5:751-763[Abstract/Free Full Text].
|
| 12.
|
Church, G. M., and W. Gilbert.
1984.
Genomic sequencing.
Proc. Natl. Acad. Sci. USA
81:1991-1995[Abstract/Free Full Text].
|
| 13.
|
Dodou, E., and R. Treisman.
1997.
The Saccharomyces cerevisiae MADS-box transcription factor Rlm1 is a target for the Mpk1 mitogen-activated protein kinase pathway.
Mol. Cell. Biol.
17:1848-1859[Abstract].
|
| 14.
|
Dolan, J.,
C. Kirkman, and S. Fields.
1989.
The yeast Ste12 protein binds to the DNA sequence mediating pheromone induction.
Proc. Natl. Acad. Sci. USA
86:5703-5707[Abstract/Free Full Text].
|
| 15.
|
Dolan, J., and S. Fields.
1991.
Cell-type-specific transcription in yeast.
Biochim. Biophys. Acta
1088:155-169[Medline].
|
| 16.
|
Errede, B., and G. Ammerer.
1989.
STE12, a protein involved in cell-type-specific transcription and signal transduction in yeast, is part of protein-DNA complexes.
Genes Dev.
3:1349-1361[Abstract/Free Full Text].
|
| 17.
|
Huang, H.,
Y. Mizukami,
Y. Hu, and H. Ma.
1993.
Isolation and characterization of the binding sequences for the product of the Arabidopsis floral homeotic gene AGAMOUS.
Nucleic Acids Res.
21:4769-4776[Abstract/Free Full Text].
|
| 18.
|
Hube, B.,
M. Monod,
D. Schofield,
A. Brown, and N. Gow.
1994.
Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans.
Mol. Microbiol.
14:87-99[Medline].
|
| 19.
|
Hwang-Shum, J.-J.,
D. Hagen,
E. Jarvis,
C. Westby, and G. Sprague.
1991.
Relative contributions of MCM1 and STE12 to transcriptional activation of a- and -specific genes from Saccharomyces cerevisiae.
Mol. Gen. Genet.
227:197-204[Medline].
|
| 20.
|
Keleher, C.,
M. Redd,
J. Schultz,
M. Carlson, and A. Johnson.
1992.
Ssn6-Tup1 is a general repressor of transcription in yeast.
Cell
68:709-719[Medline].
|
| 21.
|
Kennedy, M.,
A. Rogers,
L. Hanselmen,
D. Soll, and R. Yancey.
1988.
Variation in adhesion and cell surface hydrophobicity in Candida albicans white and opaque phenotypes.
Mycopathologia
102:149-156[Medline].
|
| 22.
|
Kolotila, M., and R. Diamond.
1990.
Effects of neutrophils and in vitro oxidants on survival and phenotypic switching of Candida albicans WO-1.
Infect. Immun.
58:1174-1179[Abstract/Free Full Text].
|
| 23.
|
Kronstad, J.,
J. A. Holly, and V. MacKay.
1987.
A yeast operator overlaps an upstream activation site.
Cell
50:369-377[Medline].
|
| 24.
|
Kuo, M., and E. Grayhack.
1994.
A library of yeast genomic MCM1 binding sites contains genes involved in cell cycle control, cell wall and membrane structure, and metabolism.
Mol. Cell. Biol.
14:348-359[Abstract/Free Full Text].
|
| 25.
|
Kuo, M.,
E. Nadeau, and E. Grayhack.
1997.
Multiple phosphorylated forms of the Saccharomyces cerevisiae Mcm1 protein include an isoform induced in response to high salt concentrations.
Mol. Cell. Biol.
17:819-832[Abstract].
|
| 26.
|
Kvaal, C.,
T. Srikantha, and D. Soll.
1997.
Misexpression of the white phase-specific gene WH11 in the opaque phase of Candida albicans affects switching and virulence.
Infect. Immun.
65:4468-4475[Abstract].
|
| 27.
| Kvaal, C., T. Srikantha, and D. R. Soll.
Unpublished data.
|
| 27a.
| Lockhart, S., and D. R. Soll. Unpublished
results.
|
| 28.
|
Lydall, D.,
G. Ammerer, and K. Nasmyth.
1991.
A new role for MCM1 in yeast: cell cycle regulation of SW15 transcription.
Genes Dev.
5:2405-2419[Abstract/Free Full Text].
|
| 29.
|
Matthews, J.,
K. Hori, and M. Cormier.
1977.
Purification and properties of Renilla reniformis luciferase.
Biochemistry
16:85-91[Medline].
|
| 30.
|
Morrow, B.,
T. Srikantha, and D. Soll.
1992.
Transcription of the gene for a pepsinogen, PEP1, is regulated by white-opaque switching in Candida albicans.
Mol. Cell. Biol.
12:2997-3005[Abstract/Free Full Text].
|
| 31.
|
Morrow, B.,
T. Srikantha,
J. Anderson, and D. Soll.
1993.
Coordinate regulation of two opaque-phase-specific genes during white-opaque switching in Candida albicans.
Infect. Immun.
61:1823-1828[Abstract/Free Full Text].
|
| 32.
|
Morrow, B.,
H. Ramsey, and D. Soll.
1994.
Regulation of phase-specific genes in the more general switching system of Candida albicans strain 3153A.
J. Med. Vet. Mycol.
32:287-294[Medline].
|
| 33.
|
Nurrish, S., and R. Treisman.
1995.
DNA binding specificity determinants in MADS-box transcription factors.
Mol. Cell. Biol.
15:4076-4085[Abstract].
|
| 34.
|
Oehlen, L.,
J. McKinney, and F. Cross.
1996.
Ste12 and Mcm1 regulate cell cycle-dependent transcription of FAR1.
Mol. Cell. Biol.
16:2830-2837[Abstract].
|
| 35.
|
Pollock, R., and R. Treisman.
1990.
A sensitive method for the determination of protein-DNA binding specificities.
Nucleic Acids Res.
18:6197-6204[Abstract/Free Full Text].
|
| 36.
|
Pomes, R.,
C. Gil, and C. Nombela.
1985.
Genetic analysis of Candida albicans morphological mutants.
J. Gen. Microbiol.
131:2107-2113[Medline].
|
| 37.
|
Primig, M.,
H. Winkler, and G. Ammerer.
1991.
The DNA binding and oligomerization domain of MCM1 is sufficient for its interaction with other regulatory proteins.
EMBO J.
10:4209-4218[Medline].
|
| 38.
|
Rikkerink, E.,
B. Magee, and P. Magee.
1988.
Opaque-white phenotype transition: a programmed morphological transition in Candida albicans.
J. Bacteriol.
170:895-899[Abstract/Free Full Text].
|
| 39.
|
Scherer, S., and D. Stevens.
1987.
Application of DNA typing methods to epidemiology and taxonomy of Candida species.
J. Clin. Microbiol.
25:675-679[Abstract/Free Full Text].
|
| 40.
|
Schiestl, R., and R. Geitz.
1989.
High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier.
Curr. Genet.
16:339-346[Medline].
|
| 41.
|
Sengupta, P., and B. Cochran.
1990.
The PRE and PQ box are functionally distinct yeast pheromone response elements.
Mol. Cell. Biol.
10:6809-6812[Abstract/Free Full Text].
|
| 42.
|
Slutsky, B.,
J. Buffo, and D. Soll.
1985.
High-frequency switching of colony morphology in Candida albicans.
Science
230:666-669[Abstract/Free Full Text].
|
| 43.
|
Slutsky, B.,
M. Staebell,
J. Anderson,
L. Risen,
M. Pfaller, and D. Soll.
1987.
"White-opaque transition": a second high-frequency switching system in Candida albicans.
J. Bacteriol.
169:189-197[Abstract/Free Full Text].
|
| 44.
|
Soll, D.,
J. Anderson, and M. Bergen.
1991.
The developmental biology of the white-opaque transition in Candida albicans, p. 20-45.
In
R. Prasad (ed.), The molecular biology of Candida albicans. Springer-Verlag, Berlin, Germany.
|
| 45.
|
Soll, D.
1992.
High-frequency switching in Candida albicans.
Clin. Microbiol. Rev.
5:183-203[Abstract/Free Full Text].
|
| 46.
|
Soll, D.
1992.
Switching and its possible role in Candida pathogenesis, p. 156-172.
In
J. E. Bennet, R. J. Hay, and P. K. Peterson (ed.), New strategies in fungal disease. Churchill Livingstone, Edinburgh, United Kingdom.
|
| 47.
| Soll, D., T. Srikantha, A. Chandrasekhar, B. Morrow, K. Schroeppel, and S. Lockhart. 1995. Gene regulation in the
white-opaque transition of Candida albicans. Can. J. Bacteriol. 73(Suppl. 1):51049-51057.
|
| 48.
|
Soll, D.
1997.
Gene regulation during high-frequency switching in Candida albicans.
Microbiology
143:279-288[Free Full Text].
|
| 49.
|
Soll, D.
1997.
The emerging molecular biology of Candida albicans.
ASM News
62:415-420.
|
| 50.
|
Sprague, G.
1990.
Combinatorial associations of regulatory proteins and the control of cell type in yeast.
Adv. Genet.
27:33-62[Medline].
|
| 51.
|
Srikantha, T., and D. Soll.
1993.
A white-specific gene in the white-opaque switching system of Candida albicans.
Gene
131:53-60[Medline].
|
| 52.
|
Srikantha, T.,
A. Chandrasekhar, and D. Soll.
1995.
Functional analysis of the promoter of the phase-specific WH11 gene of Candida albicans.
Mol. Cell. Biol.
15:1797-1805[Abstract].
|
| 53.
|
Srikantha, T.,
B. Morrow,
K. Schroppel, and D. Soll.
1995.
The frequency of integrative transformation at phase-specific genes of Candida albicans correlates with their transcriptional state.
Mol. Gen. Genet.
246:342-352[Medline].
|
| 54.
|
Srikantha, T.,
A. Klapach,
W. Lorenz,
L. Tsai,
L. Laughlin,
J. Gorman, and D. Soll.
1996.
The sea pansy Renilla reniformis luciferase serves as a sensitive bioluminescent reporter for differential gene expression in Candida albicans.
J. Bacteriol.
178:121-129[Abstract/Free Full Text].
|
| 55.
|
Srikantha, T.,
L. Tsai, and D. Soll.
1997.
The WH11 gene of Candida albicans is regulated in two distinct developmental programs through the same transcription activation sequences.
J. Bacteriol.
179:3837-3844[Abstract/Free Full Text].
|
| 56.
|
Treisman, R., and G. Ammerer.
1992.
The SRF and MCM1 transcription factors.
Curr. Opin. Genet. Dev.
2:221-226[Medline].
|
| 57.
|
White, T.,
S. Miyasaki, and N. Agabian.
1993.
Three distinct secreted aspartyl proteinases in Candida albicans.
J. Bacteriol.
175:6126-6133[Abstract/Free Full Text].
|
Journal of Bacteriology, December 1998, p. 6607-6616, Vol. 180, No. 24
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Oliver, B. G., Song, J. L., Choiniere, J. H., White, T. C.
(2007). cis-Acting Elements within the Candida albicans ERG11 Promoter Mediate the Azole Response through Transcription Factor Upc2p. Eukaryot Cell
6: 2231-2239
[Abstract]
[Full Text]
-
Park, Y.-N., Morschhauser, J.
(2005). Tetracycline-Inducible Gene Expression and Gene Deletion in Candida albicans. Eukaryot Cell
4: 1328-1342
[Abstract]
[Full Text]
-
Song, J. L., Harry, J. B., Eastman, R. T., Oliver, B. G., White, T. C.
(2004). The Candida albicans Lanosterol 14-{alpha}-Demethylase (ERG11) Gene Promoter Is Maximally Induced after Prolonged Growth with Antifungal Drugs. Antimicrob. Agents Chemother.
48: 1136-1144
[Abstract]
[Full Text]
-
Soll, D. R., Lockhart, S. R., Zhao, R.
(2003). Relationship between Switching and Mating in Candida albicans. Eukaryot Cell
2: 390-397
[Full Text]
-
Srikantha, T., Lachke, S. A., Soll, D. R.
(2003). Three Mating Type-Like Loci in Candida glabrata. Eukaryot Cell
2: 328-340
[Abstract]
[Full Text]
-
Zhao, R., Lockhart, S. R., Daniels, K., Soll, D. R.
(2002). Roles of TUP1 in Switching, Phase Maintenance, and Phase-Specific Gene Expression in Candida albicans. Eukaryot Cell
1: 353-365
[Abstract]
[Full Text]
-
Srikantha, T., Tsai, L., Daniels, K., Klar, A. J. S., Soll, D. R.
(2001). The Histone Deacetylase Genes HDA1 and RPD3 Play Distinct Roles in Regulation of High-Frequency Phenotypic Switching in Candida albicans. J. Bacteriol.
183: 4614-4625
[Abstract]
[Full Text]
-
Strauß, A., Michel, S., Morschhäuser, J.
(2001). Analysis of Phase-Specific Gene Expression at the Single-Cell Level in the White-Opaque Switching System of Candida albicans. J. Bacteriol.
183: 3761-3769
[Abstract]
[Full Text]
-
Srikantha, T., Tsai, L. K., Daniels, K., Soll, D. R.
(2000). EFG1 Null Mutants of Candida albicans Switch but Cannot Express the Complete Phenotype of White-Phase Budding Cells. J. Bacteriol.
182: 1580-1591
[Abstract]
[Full Text]
-
Lachke, S. A., Srikantha, T., Tsai, L. K., Daniels, K., Soll, D. R.
(2000). Phenotypic Switching in Candida glabrata Involves Phase-Specific Regulation of the Metallothionein Gene MT-II and the Newly Discovered Hemolysin Gene HLP. Infect. Immun.
68: 884-895
[Abstract]
[Full Text]
-
Kvaal, C., Lachke, S. A., Srikantha, T., Daniels, K., McCoy, J., Soll, D. R.
(1999). Misexpression of the Opaque-Phase-Specific Gene PEP1 (SAP1) in the White Phase of Candida albicans Confers Increased Virulence in a Mouse Model of Cutaneous Infection. Infect. Immun.
67: 6652-6662
[Abstract]
[Full Text]
-
Sonneborn, A., Tebarth, B., Ernst, J. F.
(1999). Control of White-Opaque Phenotypic Switching in Candida albicans by the Efg1p Morphogenetic Regulator. Infect. Immun.
67: 4655-4660
[Abstract]
[Full Text]